Pfizer CEO begins contributing to LinkedIn's publishing platform

Pfizer CEO Ian Read

Pfizer ($PFE) CEO Ian Read has become the first pharma executive to contribute an article to LinkedIn's ($LNKD) publishing platform. LinkedIn invited Bill Gates, Richard Branson and other business leaders to contribute posts to the platform in 2012, but no pharma executives were included at that time. Now, Read has begun contributing to the site. The Pfizer CEO's first post discusses the importance of reputation to pharma companies. "Making reputation and respect all the more important to us is knowing that we gain it in drops, but lose it in gallons," Read wrote. Blog | More

Suggested Articles

Trialbee has added ex-Lundbeck CEO Ulf Wiinberg and former Bristol-Myers Squibb SVP Lars Birgerson to its board of directors.

Researchers have enrolled 2,000 people with metastatic breast cancer in 7 months using a social media-enabled, direct-to-patient model of recruiting.

Medisafe has started pitching an app and services to increase medication adherence and facilitate patient recruitment to biopharma companies.